By: Sarah Sinclair
By On Thursday, 11 June, the first medical cannabis products were prescribed by neurologists at the Vinnytsia Regional Clinical Psychoneurological
Sarah Sinclair is the Managing Editor at [Employer]. She specializes in a diverse range of topics including cannabis and psychedelics, architecture and planning, as well as travel and tourism, with a particular focus on cannabis business, regulation, and psychedelic research. Sarah's work has been featured in notable publications such as Positive News, Forbes, and The Telegraph, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Sarah's coverage heavily focuses on healthcare, with an emphasis on medical cannabis, brain injury, and neuro research. She often includes data citations and government announcements in her articles.
Given the prevalence of scientific and health-related topics in Sarah's coverage, she may be interested in receiving pitches from experts who can provide insights into groundbreaking developments or new technologies within these fields. Additionally, given her inclusion of government announcements and legal policy regulations, sources who can offer perspectives on regulatory changes or advancements in healthcare policies may also find success when reaching out to her.
While Sarah’s geographic focus is not explicitly stated as local per se but considering that some topics covered are regional (e.g., medical cannabis in Europe), pitches related to specific regional healthcare trends or innovations could align well with her coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .